• Necrosulfonamide Enables Precision Necroptosis Assays

  2026-07-17

  Necrosulfonamide (NSA) empowers researchers to dissect necroptotic cell death with nanomolar specificity by targeting MLKL translocation. The ability to preserve mitochondrial and plasma membrane integrity under necrosis-inducing conditions sets NSA apart for high-fidelity necroptosis assays in cancer, cardiovascular, and neurodegenerative models.

• IGF2BP1–THBS1–TLR4 Axis Drives Macrophage Metabolism in Pulm

  2026-07-17

  The referenced study reveals that the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, facilitating TLR4-dependent M2 macrophage polarization and glycolytic activation. These mechanistic findings provide new insight into the metabolic regulation of macrophages in fibrotic disease and suggest potential therapeutic targets.

• Antifungal Imidazoles Target AdhE in Cryptosporidium parvum

  2026-07-16

  This study reveals that antifungal imidazoles act as low micromolar inhibitors of the bifunctional aldehyde/alcohol dehydrogenase (AdhE) in Cryptosporidium parvum, highlighting a metabolic vulnerability in this zoonotic parasite. These findings open new avenues for anti-cryptosporidial drug development through targeted natural product screening.

• Translational Leverage: N1-Methylpseudo-UTP in RNA Therapeut

  2026-07-16

  Explore how N1-Methyl-Pseudouridine-5'-Triphosphate is reshaping the landscape of translational research, driving mRNA stability and therapeutic innovation beyond conventional boundaries. This article delivers mechanistic insights, protocol optimization, and strategic vision for researchers advancing next-generation mRNA therapeutics.

• Topotecan (SKF104864): Applied Workflows in Cancer Research

  2026-07-15

  Topotecan (SKF104864) empowers cancer researchers with precise control over DNA damage, apoptosis induction, and cell cycle arrest, particularly in challenging glioma and pediatric solid tumor models. This article demystifies advanced workflows, troubleshooting, and comparative advantages for translational and in vitro applications—showcasing how APExBIO’s Topotecan sets the benchmark for reproducibility and assay innovation.

• EZ Cap EGFP mRNA 5-moUTP: Workflow Optimization & Immune-Sil

  2026-07-15

  EZ Cap EGFP mRNA 5-moUTP enables robust, immune-silent gene expression for translational assays, live-cell imaging, and mRNA delivery validation. Its advanced Cap 1 structure and 5-moUTP modification set a new benchmark for reproducibility and translational efficiency—empowering more reliable mRNA studies across cell systems.

• Saquinavir: Benchmark HIV Protease Inhibitor for Advanced Re

  2026-07-14

  Saquinavir is a potent HIV protease inhibitor with verified efficacy in preclinical antiretroviral drug research. Its role extends to permeability modeling and cancer studies, with well-characterized physicochemical and mechanistic properties. This article details its biological basis, experimental benchmarks, and workflow parameters for reproducible use.

• Topotecan HCl: Applied Workflows for Topoisomerase 1 Inhibit

  2026-07-14

  Topotecan HCl is a potent topoisomerase 1 inhibitor with validated antitumor activity in preclinical cancer models. This article translates mechanistic insights and reference innovations into actionable protocols, troubleshooting, and workflow optimizations—empowering researchers to extract maximal value from in vitro and in vivo applications.

• γH2AX DNA Damage Detection Kit: Precision DSB Detection for

  2026-07-13

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) unlocks high-sensitivity DNA double-strand break detection for genotoxicity, apoptosis, and DNA repair research. Its robust immunofluorescence workflow and adaptability to cutting-edge modalities like FLASH-RT make it an indispensable tool for labs aiming for reproducible, quantitative insights into DNA damage response.

• Lnc21q22.11 Suppresses Gastric Cancer via MEK/ERK Pathway In

  2026-07-13

  The reference study identifies Lnc21q22.11 as a novel long non-coding RNA that inhibits gastric cancer growth by targeting the MEK/ERK signaling pathway. These findings reveal new mechanistic insights and highlight Lnc21q22.11 as a potential molecular target for gastric cancer therapy.

• 7-Ethyl-10-hydroxycamptothecin: Potent SN-38 Pathway Inhibit

  2026-07-12

  7-Ethyl-10-hydroxycamptothecin (SN-38) is a nanomolar-potency DNA topoisomerase I inhibitor with dual mechanisms in advanced colon cancer research. It induces S-phase and G2 phase arrest and apoptosis, and also disrupts FUBP1-mediated transcriptional regulation. This compound, available from APExBIO as SKU N2133, is benchmarked for high-purity, reproducible in vitro studies.

• Risedronate Sodium: Next-Gen Delivery and Translational Impa

  2026-07-10

  Explore how Risedronate Sodium, a leading FPP synthase inhibitor, is reshaping osteoporosis and emphysema research via advanced nanoformulations and transdermal systems. This in-depth analysis reveals actionable insights for experimental design and translational potential.

• Hierarchical Targeting for Diabetic Periodontitis: Mitochond

  2026-07-09

  This study introduces a hierarchically targeted, ROS-responsive nanoparticle-hydrogel platform that selectively repairs mitochondrial dysfunction in M1 macrophages to treat diabetic periodontitis. By disrupting the ROS-driven inflammatory loop, the strategy significantly reduces tissue destruction and supports bone regeneration, highlighting a novel therapeutic pathway for chronic inflammation in diabetic contexts.

• Genotyping Kit for Target Alleles: Fast PCR from Diverse Sam

  2026-07-09

  Accelerate genetic analysis of insects, tissues, fish, and cells with the Genotyping Kit for target alleles. Streamline PCR workflows using single-tube, phenol-free DNA prep—ideal for high-throughput and contamination-sensitive research.

• Ceapin-A7 as a Selective ER Stress Blocker: Advanced Protoco

  2026-07-08

  Ceapin-A7 empowers researchers with precise, selective ER stress modulation through robust ATF6α pathway inhibition. Discover optimized workflows, troubleshooting strategies, and actionable insights for dissecting the unfolded protein response in disease models.

16447 records 1/1097 page Next 12345 下5页 Last page